At Kineticos, we target high-growth opportunities across the life sciences ecosystem, including investing in specialized pharma services, tackling global health threats like antimicrobial resistance , and advancing transformative treatments for cancer, neurodegenerative, and rare diseases.
Learn MoreExplore our diverse and cutting-edge portfolio.
Kineticos is led by seasoned life sciences operators, executives and investors with deep scientific, business, and operational expertise—and a track record of successful exits.
Our Team)
Combination creates a scaled U.S. advanced therapies CDMO with broader technical expertise and capabilities from early development through commercial supply.…
){kind=logo}
SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes…
)
Clinically meaningful improvements in global IBS symptom severity observed as early as Week 1 and sustained through Week 7, with…